Several Toyocamycin (4) analogues were examined for their ability to inhibit HCV RNA in a replicon assay. Among the compounds examined 4-methylthio (18) and 5-carboxamide oxime derivatives (23 and 27) of Toyocamycin were found to have good activity and selectivity.
![1H-Pyrrolo[2,3-d]pyrimidine-5-carboximidamide,4,7-dihydro-N-hydroxy-4-oxo-7-b-D-ribofuranosyl结构式](https://image.chemsrc.com/caspic/477/22242-92-8.png)
![4-chloro-5-cyano-7-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine结构式](https://image.chemsrc.com/caspic/289/57071-52-0.png)
![5-chloro-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4,9-triazabicyclo[4.3.0]nona-2,4,7,10-tetraene-7-carbonitrile结构式](https://image.chemsrc.com/caspic/495/52443-16-0.png)
![3,4-dihydro-4-oxo-7-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine-5-carbonitrile结构式](https://image.chemsrc.com/caspic/354/57071-68-8.png)
![9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylsulfanyl-2,4,9-triazabicyclo[4.3.0]nona-2,4,7,10-tetraene-7-carbonitrile结构式](https://image.chemsrc.com/caspic/424/51112-63-1.png)
![1H-Pyrrolo[2,3-d]pyrimidine-5-carboximidamide,4,7-dihydro-4-oxo-7-b-D-ribofuranosyl结构式](https://image.chemsrc.com/caspic/439/22242-93-9.png)
![1H-Pyrrolo[2,3-d]pyrimidine-5-carbothioamide,4,7-dihydro-4-oxo-7-b-D-ribofuranosyl结构式](https://image.chemsrc.com/caspic/353/22242-95-1.png)
![1H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide,4,7-dihydro-4-oxo-7-b-D-ribofuranosyl结构式](https://image.chemsrc.com/caspic/391/22242-94-0.png)
![9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methoxy-2,4,9-triazabicyclo[4.3.0]nona-2,4,7,10-tetraene-7-carbonitrile结构式](https://image.chemsrc.com/caspic/413/57071-71-3.png)